These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20071304)

  • 21. [Immunohistochemical markers in colorectal cancer].
    Lindebjerg J
    Ugeskr Laeger; 2005 Oct; 167(44):4168-70. PubMed ID: 16266569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression genomics in breast cancer research: microarrays at the crossroads of biology and medicine.
    Miller LD; Liu ET
    Breast Cancer Res; 2007; 9(2):206. PubMed ID: 17397520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Microarray technology--potential in cancer research].
    Forus A; Sørlie T; Børresen-Dale AL; Myklebost O
    Tidsskr Nor Laegeforen; 2001 Sep; 121(21):2498-503. PubMed ID: 11875927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular diagnostics in melanoma.
    Carlson JA; Ross JS; Slominski A; Linette G; Mysliborski J; Hill J; Mihm M
    J Am Acad Dermatol; 2005 May; 52(5):743-75; quiz 775-8. PubMed ID: 15858465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of genomic tools for the molecular understanding of breast cancer and to guide personalized medicine.
    Foekens JA; Wang Y; Martens JW; Berns EM; Klijn JG
    Drug Discov Today; 2008 Jun; 13(11-12):481-7. PubMed ID: 18549973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Report of the National Oncology Research and Developement Consortium, 2003].
    Tímár J
    Magy Onkol; 2004; 48(1):75-9. PubMed ID: 15105900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Application of genetic diagnosis for colorectal cancer].
    Shimada M
    Rinsho Byori; 2001 Dec; 49(12):1237-41. PubMed ID: 11797394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Molecular factors determine primary and secondary therapy of breast carcinoma].
    Eppenberger U; Kueng W; Eppenberger-Castori S; von Landenberg EM; Müller H
    Ther Umsch; 1997 Aug; 54(8):451-6. PubMed ID: 9381415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin alpha2 as a potential novel prognostic marker in breast cancer.
    Dahl E; Kristiansen G; Gottlob K; Klaman I; Ebner E; Hinzmann B; Hermann K; Pilarsky C; Dürst M; Klinkhammer-Schalke M; Blaszyk H; Knuechel R; Hartmann A; Rosenthal A; Wild PJ
    Clin Cancer Res; 2006 Jul; 12(13):3950-60. PubMed ID: 16818692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrated breast cancer genomics.
    Edgren H; Kallioniemi O
    Cancer Cell; 2006 Dec; 10(6):453-4. PubMed ID: 17157784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterogeneous expression of the aquaporin 1 (AQP1) water channel in tumors of the prostate, breast, ovary, colon and lung: a study using high density multiple human tumor tissue microarrays.
    Mobasheri A; Airley R; Hewitt SM; Marples D
    Int J Oncol; 2005 May; 26(5):1149-58. PubMed ID: 15809704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and classification of differentially expressed genes in non-small cell lung cancer by expression profiling on a global human 59.620-element oligonucleotide array.
    Hofmann HS; Bartling B; Simm A; Murray R; Aziz N; Hansen G; Silber RE; Burdach S
    Oncol Rep; 2006 Sep; 16(3):587-95. PubMed ID: 16865260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The multidisciplinary management of gastrointestinal cancer. The use of molecular markers in the diagnosis and treatment of colorectal cancer.
    Tejpar S
    Best Pract Res Clin Gastroenterol; 2007; 21(6):1071-87. PubMed ID: 18070704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A bioinformatic approach to the identification of candidate genes for the development of new cancer diagnostics.
    Musumarra G; Barresi V; Condorelli DF; Scirè S
    Biol Chem; 2003 Feb; 384(2):321-7. PubMed ID: 12675527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information.
    Montero-Conde C; Martín-Campos JM; Lerma E; Gimenez G; Martínez-Guitarte JL; Combalía N; Montaner D; Matías-Guiu X; Dopazo J; de Leiva A; Robledo M; Mauricio D
    Oncogene; 2008 Mar; 27(11):1554-61. PubMed ID: 17873908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. State of the science: molecular classifications of breast cancer for clinical diagnostics.
    Robison JE; Perreard L; Bernard PS
    Clin Biochem; 2004 Jul; 37(7):572-8. PubMed ID: 15234238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Colon carcinoma: molecular diagnosis and therapy].
    Blum HE
    Praxis (Bern 1994); 1997 Sep; 86(39):1504-9. PubMed ID: 9411670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defining the molecular biology of inflammatory breast cancer.
    Charafe-Jauffret E; Tarpin C; Viens P; Bertucci F
    Semin Oncol; 2008 Feb; 35(1):41-50. PubMed ID: 18308145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.